Nakamoto Inc.
NAKANasdaq
$4.06
↑ +2.3%Jul 17 close · end-of-day
Price
1Y↓ -99.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2.6M
Enterprise Value
-$32.7M
P/E
—
P/S
0.9
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$2.8M
Net Income (TTM)
-$290.0M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
-11314.3%
Net Margin
-10180.3%
ROE
-79.0%
ROIC
-76.7%
Debt / Equity
—
Net Cash
$35.3M
Return 1Y
-99.1%
Company profile
Kindly MD, Inc. is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.
- CEO
- Tim Pickett
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- Utah
- Website
- kindlymd.com
Management & directors
- Bailey David FChief Executive Officer
- Evans Tyler MatthewChief Investment Officer
- Dalton John MerrittChief Accounting Officer
- Gendron Teresa SChief Financial Officer
- Barrera JaredChief Financial Officer
- Creighton Andrew JohnChief Commercial Officer
- Fabiano AmandaChief Operating Officer
- Pickett TimothyChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
NAKA Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.6M↑ +177.1%
Diluted EPS-$0.38↑ +123.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $3.8M | $2.7M | $1.8M |
| Gross profit | — | — | — |
| Operating income | -$1.6M | -$3.3M | -$197.1M |
| Net income | -$1.6M | -$3.6M | -$52.2M |
| Diluted EPS | -$0.36 | -$0.67 | -$0.26 |
| Operating cash flow | -$449,489.00 | -$3.1M | -$23.5M |
| Free cash flow | -$463,909.00 | -$3.1M | — |
| Gross margin | — | — | — |
| Operating margin | -43.0% | -123.1% | -10824.0% |
| Net margin | -42.9% | -133.0% | -2867.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $639,057.00 | $647,867.00 | $603,887.00 | $580,000.00 | $408,527.00 | $388,209.00 | $444,579.00 | $1.6M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.0M | -$1.0M | -$1.0M | -$1.0M | -$2.4M | -$10.4M | -$183.3M | -$126.2M |
| Net income | -$1.3M | -$1.0M | -$1.0M | -$1.0M | -$2.4M | -$86.0M | $37.3M | -$238.8M |
| Diluted EPS | -$0.26 | -$0.17 | -$0.18 | -$0.17 | -$0.35 | -$0.42 | $0.68 | -$0.38 |
| Operating cash flow | -$913,537.00 | -$1.0M | -$901,530.00 | -$865,000.00 | -$1.9M | -$13.2M | -$7.6M | -$23.3M |
| Free cash flow | -$913,537.00 | -$1.0M | -$901,532.00 | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -162.3% | -162.0% | -169.3% | -179.7% | -585.4% | -2680.4% | -41230.1% | -7851.3% |
| Net margin | -206.5% | -156.5% | -165.8% | -179.0% | -590.9% | -22162.2% | 8380.7% | -14858.5% |
Company news
May 12, 2025
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-28 | Bailey David F· Chief Executive Officer | Buy | 48,000 | $5.59 | $268,320.00 | filing |
| 2026-05-28 | Bailey David F· Chief Executive Officer | Buy | 7,115 | $5.79 | $41,195.85 | filing |
| 2026-05-27 | Bailey David F· Chief Executive Officer | Buy | 79,104 | $4.68 | $370,206.72 | filing |
| 2026-05-27 | Bailey David F· Chief Executive Officer | Buy | 25,729 | $5.33 | $137,135.57 | filing |
| 2026-05-26 | Bailey David F· Chief Executive Officer | Buy | 31,500 | $5.58 | $175,770.00 | filing |
| 2026-03-12 | Evans Tyler Matthew· Chief Investment Officer | Award | 600,000 | $0.00 | $0.00 | filing |
| 2026-02-20 | Bailey David F· Chief Executive Officer | Award | 108,200,628 | $0.00 | $0.00 | filing |
| 2026-02-20 | Evans Tyler Matthew· Chief Investment Officer | Award | 17,841,993 | $0.00 | $0.00 | filing |
| 2026-02-20 | Evans Tyler Matthew· Chief Investment Officer | Award | 17,841,993 | $0.00 | $0.00 | filing |
| 2025-12-16 | Gendron Teresa S· Chief Financial Officer | Award | 2,624,671 | $0.00 | $0.00 | filing |
| 2025-12-16 | Dalton John Merritt· Chief Accounting Officer | Award | 1,574,803 | $0.00 | $0.00 | filing |
| 2025-09-22 | Creighton Andrew John· Chief Commercial Officer | Award | 601,503 | $0.00 | $0.00 | filing |
| 2025-09-22 | Evans Tyler Matthew· Chief Investment Officer | Award | 601,503 | $0.00 | $0.00 | filing |
| 2025-09-22 | YUSKO MARK W | Award | 112,781 | $0.00 | $0.00 | filing |
| 2025-09-22 | McNulty Perianne Boring | Award | 112,781 | $0.00 | $0.00 | filing |
| 2025-09-22 | Blackburn Charles Phillip | Award | 112,781 | $0.00 | $0.00 | filing |
| 2025-09-22 | Barrera Jared· Chief Financial Officer | Award | 6,400 | $0.00 | $0.00 | filing |
| 2025-09-22 | Pickett Timothy· Chief Medical Officer | Award | 37,593 | $0.00 | $0.00 | filing |
| 2025-09-22 | Pickett Timothy· Chief Medical Officer | Award | 26,129 | $0.00 | $0.00 | filing |
| 2025-09-22 | Pickett Timothy· Chief Medical Officer | Award | 10,146 | $0.00 | $0.00 | filing |
| 2025-09-22 | Pickett Timothy· Chief Medical Officer | Award | 18,378 | $0.00 | $0.00 | filing |
| 2025-09-22 | Weiss Eric Stanton | Award | 112,781 | $0.00 | $0.00 | filing |
| 2025-09-22 | Xethalis Gregory Elias | Award | 112,781 | $0.00 | $0.00 | filing |
| 2025-09-22 | Fabiano Amanda· Chief Operating Officer | Award | 751,879 | $0.00 | $0.00 | filing |
| 2025-09-22 | Fabiano Amanda· Chief Operating Officer | Award | 3,383,458 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.